Through the isolation, purification and cultivation processes in Steminent’s system, Stemchymal® possesses unique therapeutic advantages in:
- In vivo sustainability – Stemchymal® can exert sustainable therapeutic effects with more effective cell number required.
- Immunomodulatory ability – Stemchymal® presents superior T-cell modulation ability.
- Homing ability – Stemchymal® can migrate and engraft into the specific injured site in a more effective fashion.
- Multipotent differentiation ability — Stemchymal®, under Steminent’s technology platform, are able to differentiate into specialized cell types from mesoderm, endoderm and ectoderm.